MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

Genes and Development

Volumn 23, Issue 18, 2009, Pages 2166-2178

  Xin, Mei ^a   Small, Eric M ^a   Sutherland, Lillian B ^a   Qi, Xiaoxia ^a   McAnally, John ^a   Plato, Craig F ^b   Richardson, James A ^a,c   Bassel Duby, Rhonda ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Gilead Colorado Inc   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Actin signaling; MicroRNA; Myocardin; Serum response factor; Vascular disease

Indexed keywords

ACTIN; MICRORNA; MICRORNA 143; MICRORNA 145; MYOCARDIN; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CELL DAMAGE; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA ANALYSIS; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; STRESS FIBER; TISSUE DIFFERENTIATION; VASCULAR DISEASE;

ACTINS; ANIMALS; BASE SEQUENCE; CAROTID ARTERY INJURIES; CELLS, CULTURED; CYTOSKELETON; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTATION; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; NUCLEAR PROTEINS; RATS; SEQUENCE ALIGNMENT; TRANS-ACTIVATORS;

MUS;

EID: 70349125875     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1842409     Document Type: Article

References (53)

1. Barkalow KL, Italiano JE Jr, Chou DE, Matsuoka Y, Bennett V, Hartwig JH. 2003. α-Adducin dissociates from F-actin and spectrin during platelet activation. J Cell Biol 161: 557-570. (Pubitemid 36578580)
2. Barringhaus KG, Zamore PD. 2009. MicroRNAs: Regulating a change of heart. Circulation 119: 2217-2224.
3. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, et al. 2009. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713.
5. Chen J, Kitchen CM, Streb JW, Miano JM. 2002. Myocardin: A component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 34: 1345-1356. (Pubitemid 35244412)
6. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233. (Pubitemid 43177239)
7. Chen JF, Callis TE, Wang DZ. 2009. microRNAs and muscle disorders. J Cell Sci 122: 13-20.
8. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C. 2009. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166.
9. Choi WY, Giraldez AJ, Schier AF. 2007. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318: 271-274.
10. Condorelli G, Dimmeler S. 2008. MicroRNAs: Components of an integrated system controlling cardiac development, physiology, and disease pathogenesis. Cardiovasc Res 79: 551-552.
11. Cordes KR, Srivastava D. 2009. MicroRNA regulation of cardiovascular development. Circ Res 104: 724-732.
12. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. 2009. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
13. Davis EC. 1993. Smooth muscle cell to elastic lamina connections in developing mouse aorta. Role in aortic medial organization. Lab Invest 68: 89-99.
14. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK, Parmacek MS. 2003. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 23: 2425-2437. (Pubitemid 36351024)
15. Eiseler T, Doppler H, Yan IK, Kitatani K, Mizuno K, Storz P. 2009. Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol 11: 545-556.
16. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka Y, Bennett V, Matsuura Y, Kaibuchi K. 1999. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 145: 347-361. (Pubitemid 29198306)
17. Gardner K, Bennett V. 1987. Modulation of spectrin-actin assembly by erythrocyte adducin. Nature 328: 359-362. (Pubitemid 17097660)
18. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27: 91-105. (Pubitemid 46991392)
19. Hinson JS, Medlin MD, Lockman K, Taylor JM, Mack CP. 2007. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. Am J Physiol Heart Circ Physiol 292: H1170-H1180. doi: 10.1152/ajpheart.00864.2006. (Pubitemid 46246971)
20. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. 2005. Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
21. Kumar A, Lindner V. 1997. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17: 2238-2244. (Pubitemid 28057127)
22. Kuwahara K, Barrientos T, Pipes GC, Li S, Olson EN. 2005. Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol Cell Biol 25: 3173-3181. (Pubitemid 40464319)
23. Li S, Wang DZ, Wang Z, Richardson JA, Olson EN. 2003. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci 100: 9366-9370. (Pubitemid 37033934)
24. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN. 2008. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes & Dev 22: 3242-3254.
25. McFadden DG, Charite J, Richardson JA, Srivastava D, Firulli AB, Olson EN. 2000. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development 127: 5331-5341. (Pubitemid 32049189)
26. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R. 2009. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 11: 257-268.
27. Miano JM, Long X, Fujiwara K. 2007. Serum response factor: Master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292: C70-C81. doi: 10.1152/ajpcell.00386.2006. (Pubitemid 46115122)
28. Miralles F, Posern G, Zaromytidou AI, Treisman R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113: 329-342. (Pubitemid 36556115)
29. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228. (Pubitemid 28180855)
30. Moller W, Moller G. 1994. Chemical dehydration for rapid paraffin embedding. Biotech Histochem 69: 289-290. (Pubitemid 24295412)
31. Nagai R, Suzuki T, Aizawa K, Shindo T, Manabe I. 2005. Significance of the transcription factor KLF5 in cardiovascular remodeling. J Thromb Haemost 3: 1569-1576. (Pubitemid 41716541)
32. Naya FJ, Wu C, Richardson JA, Overbeek P, Olson EN. 1999. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126: 2045-2052. (Pubitemid 29271690)
33. Niu Z, Li A, Zhang SX, Schwartz RJ. 2007. Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol 19: 618-627. (Pubitemid 350216421)
34. Owens GK. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517.
35. Parmacek MS. 2007. Myocardin-related transcription factors: Critical coactivators regulating cardiovascular development and adaptation. Circ Res 100: 633-644.
36. Pipes GC, Creemers EE, Olson EN. 2006. Themyocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes & Dev 20: 1545-1556.
37. San Martin A, Lee MY, Williams HC, Mizuno K, Lassegue B, Griendling KK. 2008. Dual regulation of cofilin activity by LIM kinase and Slingshot-1L phosphatase controls platelet-derived growth factor-induced migration of human aortic smooth muscle cells. Circ Res 102: 432-438. (Pubitemid 351651101)
38. Suzuki T, Sawaki D, Aizawa K, Munemasa Y, Matsumura T, Ishida J, Nagai R. 2009. Kruppel-like factor 5 shows proliferation-specific roles in vascular remodeling, direct stimulation of cell growth, and inhibition of apoptosis. J Biol Chem 284: 9549-9557.
39. van Rooij E, Olson EN. 2007. MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376.
40. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. 2006. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci 103: 18255-18260. (Pubitemid 44871645)
41. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. 2007. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579. (Pubitemid 46683138)
42. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci 105: 13027-13032.
43. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105: 851-862. (Pubitemid 32635087)
44. Wang Z, Wang DZ, Pipes GC, Olson EN. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci 100: 7129-7134. (Pubitemid 36706404)
45. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189. (Pubitemid 38374315)
46. Wang C, Han M, Zhao XM, Wen JK. 2008. Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. J Biochem 144: 313-321.
47. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271.
48. Wong K, Ren XR, Huang YZ, Xie Y, Liu G, Saito H, Tang H,Wen L, Brady-Kalnay SM, Mei L, et al. 2001. Signal transduction in neuronal migration: Roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 107: 209-221. (Pubitemid 33035947)
49. XinM, Davis CA,Molkentin JD, Lien CL, Duncan SA, Richardson JA, Olson EN. 2006. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci 103: 11189-11194.
50. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. 2009. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658.
51. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, et al. 2007. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491. (Pubitemid 46559834)
52. Yoshida T, Sinha S, Dandre F, Wamhoff BR, Hoofnagle MH, Kremer BE, Wang DZ, Olson EN, Owens GK. 2003. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 92: 856-864. (Pubitemid 36542526)
53. Yoshida T, Kaestner KH, Owens GK. 2008. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 102: 1548-1557.